Inotuzumab-ozogamicinThrombocytopenia: 2 case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1836卷 / 1期

关键词：

D O I：

10.1007/s40278-021-88245-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：426 / 426

相关论文

共 50 条

[41] OmalizumabAnaphylaxis: 2 case report
Reactions Weekly, 2020, 1808 (1) : 240 - 240
[42] AmiodaroneHypothyroidism: 2 case report
Reactions Weekly, 2019, 1762 (1) : 31 - 31
[43] AntineoplasticsPellagra: 2 case report
Reactions Weekly, 2020, 1788 (1) : 37 - 37
[44] RibavirinAnaemia: 2 case report
Reactions Weekly, 2015, 1535 (1) : 185 - 185
[45] EribulinMalaise: 2 case report
Reactions Weekly, 2020, 1802 (1) : 134 - 134
[46] LenvatinibHypothyroidism: 2 case report
Reactions Weekly, 2016, 1583 (1) : 678 - 678
[47] AmiodaroneThyrotoxicosis: 2 case report
Reactions Weekly, 2019, 1779 (1) : 20 - 20
[48] NaloxoneDyskinesia: 2 case report
Reactions Weekly, 2021, 1866 (1) : 301 - 301
[49] InsulinHypoglycaemia: 2 case report
Reactions Weekly, 2018, 1695 (1) : 222 - 222
[50] RasburicaseMethemoglobinemia: 2 case report
Reactions Weekly, 2015, 1542 (1) : 191 - 191

← 1 2 3 4 5 →